Talis Biomedical Corporation announced the appointment of Brian Blaser to President, Chief Executive Officer and Director. Kim Popovits, currently serving as Interim Chief Executive Officer, will resume her role as Director on the Board of Talis. These changes will be effective December 1, 2021. Mr. Blaser has more than 25 years of senior leadership experience in the in-vitro diagnostics industry, including 17 years at Abbott Laboratories. During his tenure at Abbott, Mr. Blaser most recently served as EVP of Diagnostics Products overseeing the company?s multi-billion-dollar global diagnostics organization, including its core laboratory, point of care, rapid diagnostics and molecular diagnostics businesses. Earlier in his career, Mr. Blaser held key leadership positions in operations, finance and engineering with the Ortho-Clinical Diagnostics division of Johnson & Johnson, Eastman Kodak and General Motors. He currently serves as an Executive Advisor to Water Street Healthcare Partners and as a Non-Executive Director on the board of Rockley Photonics. Mr. Blaser holds a Bachelor of Science in Mechanical Engineering Technology from the University of Dayton and a Master of Business Administration from the Rochester Institute of Technology.